Vivaglobin (Immune Globulin Subcutaneous Human) - Current Clinical Trials

Vivaglobin Related Clinical Trials

Evaluation of Efficacy and Tolerability of Hizentra� [Recruiting]

Pharmacokinetics, Safety, and Tolerability of Subcutaneous GAMUNEX-C in Pediatric Subjects With Primary Immunodeficiency [Recruiting]

Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study) [Not yet recruiting]

Tolerability and Safety of Immune Globulin Subcutaneous Solution and rHuPH20 in Primary Immunodeficiency Diseases (PID) [Recruiting]

Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study) [Not yet recruiting]

Immune Globulin Subcutaenous (Human), 20% [Recruiting]

Phase 2/3 Study of IGSC, 20% in PIDD [Recruiting]

Retrospective Chart Review of Subcutaneous IgG Use in Infants [Recruiting]

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20) [Recruiting]